Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Lung Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06117644
What this trial is testing

The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC

Who this might be right for
Non Small Cell Lung CancerEGFR Gene MutationNon Small Cell Lung Cancer Stage IIIA+1 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 30
Large-scale testing (Phase 3)Looking for participantsNCT06417814
What this trial is testing

Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-small Cell Lung Cancer
AstraZeneca 744
Testing effectiveness (Phase 2)UnknownNCT04706949
What this trial is testing

Pyrotinib Combined With Pemetrexed Plus Carboplatin in the First-line Treatment

Who this might be right for
Lung Cancer, Non-small Cell
Fudan University 26
Testing effectiveness (Phase 2)Study completedNCT00138658
What this trial is testing

OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Achieve Life Sciences 85
Large-scale testing (Phase 3)Active Not RecruitingNCT04923906
What this trial is testing

Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR Mutations

Who this might be right for
Non-small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 624
Large-scale testing (Phase 3)Study completedNCT03215706
What this trial is testing

Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 719
Not applicableEnded earlyNCT00769652
What this trial is testing

Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer

Who this might be right for
Lung CancerMalnutritionPancreatic Cancer+2 more
Rutgers, The State University of New Jersey 8
Testing effectiveness (Phase 2)Study completedNCT00541099
What this trial is testing

Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 11
Testing effectiveness (Phase 2)Study completedNCT00309998
What this trial is testing

Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Rochester 50
Testing effectiveness (Phase 2)WithdrawnNCT06555263
What this trial is testing

Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung CancerLung Cancer MetastaticLung Cancer, Nonsmall Cell+3 more
Sutro Biopharma, Inc.
Not applicableStudy completedNCT00094822
What this trial is testing

Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
Amgen 90
Testing effectiveness (Phase 2)WithdrawnNCT02495636
What this trial is testing

Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Yale University
Testing effectiveness (Phase 2)Study completedNCT02303977
What this trial is testing

Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy

Who this might be right for
Patients With Stage IV or Recurrent Adenocarcinoma of the Lung
Abramson Cancer Center at Penn Medicine 37
Large-scale testing (Phase 3)Ended earlyNCT02893332
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)

Who this might be right for
Stage IV EGFR Mutated Non-Small Cell Lung Cancer
Sichuan Provincial People's Hospital 200
Not applicableUnknownNCT05513664
What this trial is testing

Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung CancerEGFR Exon20 Insertion Mutations
Shanghai JMT-Bio Inc. 80
Early research (Phase 1)WithdrawnNCT01562301
What this trial is testing

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Chemotherapeutic Agent ToxicityLung Cancer
M.D. Anderson Cancer Center
Not applicableUnknownNCT06154967
What this trial is testing

To Explore the Effect of Immune-induced Stereotactic Body Radiotherapy (SBRT) on Reversing Immunoresistance in Stage IIIc/IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 20
Post-approval studies (Phase 4)Active Not RecruitingNCT05689671
What this trial is testing

Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
Nikolaj Frost MD 136
Early research (Phase 1)Active Not RecruitingNCT04007744
What this trial is testing

Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+19 more
Mayo Clinic 36
Early research (Phase 1)Ended earlyNCT02468661
What this trial is testing

A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 23
Next Page